Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional Dyspepsia: Validation of a PDS Symptom Questionnaire with Itopride
2012-004296-39Phase 4Completed
- Sponsor
- Targid
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of itopride in functional dyspepsia (FD), sponsored by Targid. Primary endpoint: Responsiveness of the new PRO instrument for PDS symptom severity. Started Jan 2013; status: completed.
02
Drugs
itopride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2012-004296-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004296-39.